Clinic for Hematology
Prof. Dr. med. Ulrich Duehrsen
+49 (0) 201-723-24 13
+49 (0) 201-723-59 28
PD Dr. med. Jan Duerig
Facts and Figures
Patients with diffuse non-Hodgkins lymphoma: 450
Patients with blood cancer, myeloid leukemia: 300
Patients with blood cancer, lymphatic leukemia: 200
Intermediate and high grade intense chemotherapy regimens: approximately 600
Isolation of hematopoetic stem cells from bone marrow and peripheral blood for transplants: 100
Research and treatment of non-Hodgkins lymphomas. Application, trials, and introduction of state-of-the-art therapeutic procedures including high-dose therapy combined with autologous blood stem cell transplants, immune therapy and tumor-specific, molecularly defined treatment forms. Entire spectrum of hematology, hemato-oncology, and hemostaseology. Outpatient treatment in the hematology clinic and its associated chemotherapy unit. Allogeneic blood stem cell transplants are carried out at the Clinic for Bone Marrow Transplants.
- Hematologic outpatient clinic
- Hematologic chemotherapy clinic
- Blood clotting clinic
Fields of Research
Clinical trials (phases I to IV) for the improvement of outcomes in acute and chronic leukemia, myelodysplastic and myeloproliferative syndromes, Hodgkins and non-Hodgkins lymphomas, multiple myelomas, immune defects, anemia, thrombocytopenia, and other blood clotting disorders.
Experimental research in the fields of genetic susceptibility to blood disorders, malignant transformation of blood forming cells, molecular characterization of hematopoetic, endothelial and leukemic stem cells, the importance of the hematopoetic micro-environment for the manifestation of leukemia, and the utilization of tumor-specific molecular aberrations for targeted pharmacotherapeutic interventions.
Number of patients
The clinic employs 18 physicians, including 10 specialists in internal medicine and 8 in hematology and internal medicine oncology, as well as 35 nurses. Of all employees, 18% have advanced specialized training in the clinic's fields.